US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Release time：2024-05-21 18:43:13 Source：Stellar Station news portal
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
Related articles
- Not so Cool Britannia! Noel Gallagher gives damning verdict on Keir Starmer
- Eat nuts and seeds to fight off disease: Healthy snacks should be added to 5
- REVEALED: Former Tory minister who leapt to Angela Rayner's defence... is working for Labour
- Musgrove goes 7 innings and Bogaerts homers as the Padres beat the Blue Jays 6
- Siblings trying to make US water polo teams for Paris Olympics
- Horrifying moment caregiver, 26, smacks 93
- China urges U.S. to formulate universal data security rules to enable orderly, free data flows
- Lou Groza Award winner Graham Nicholson transferring to Alabama
- Company wins court ruling to continue development of Michigan factory serving EV industry
- Glimpses of Beijing through windows and doorways
- Nuggets blow 20
- The rainbow princess: Kate Middleton's stylish
- Now Brits holidaying in Tenerife could be slapped with a tourist tax, Canary Islands leader warns
- Global exhibitors seek opportunities at consumer expo in Hainan
- Four people killed in a house explosion in southwestern Missouri
- North Korea has fired multiple missiles into the ocean, South Korea says
- Hurricanes get a quick boost from Evgeny Kuznetsov addition to start NHL playoffs
- Terry Anderson, AP reporter abducted in Lebanon and held captive for years, has died at 76
- Jessica Biel CHOPS her long locks into a bob after book signing in Studio City
- Stone carvings found inside cave of China's Longmen Grottoes
Random recommendation
- Copyright © 2024 Powered by US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition ,Stellar Station news portal sitemap